AUG 01, 2017 7:06 PM PDT

Uncovering HIV Hiding Spots in the Body

WRITTEN BY: Kara Marker

Scientists have known for a while that HIV hides in the body, undetected by the immune system and unaffected by antiretroviral drugs, but where specifically? Researchers from the University of Michigan have narrowed it down to specific cells in the bone marrow, highlighting a new opportunity for an anti-HIV drug that could finally get rid of the virus completely.

 

Credit: University of Michigan

 

HIV is hard to get rid of entirely. Despite the latest anti-retroviral drug technologies, HIV hides in the body, waiting to “pounce” once the drugs stop to cause an infection, which can lead to AIDS. The way HIV “lurks” is similar to the way the varicella virus, which causes chickenpox, hides out in long-living nerve cells and causes shingles later in life. Current drugs keep HIV at bay, preventing AIDS, but they don’t completely rid the body of the virus.

"Looking for the cells that harbor functional HIV is like searching for a needle in a haystack,” explained research leader Kathleen Collins, MD, PhD. “Our new results expand our understanding of the type of cells that can do it.”

Thanks to several long-term HIV patients who donated bone marrow samples, Collins and her team were able to observe HIV hiding in bone marrow cells, and they saw that HIV was present in many different cell types. Cells harboring the virus divide, passing HIV genetic material to future generations of cells.

They found that HIV hides in hematopoietic progenitor cells (HPCs), which replace blood cells as they get older and die, “blood cells in waiting.” Here, HIV hijacks the HPC’s cellular machinery so the cell starts cranking out viral proteins. To do so, HIV attaches to a CD4 receptor on the surface of HPCs. Two HIV subtypes are capable of binding CD4, those utilizing CXCR4 and CCR5 receptors.

HPCs can live for years, making them a smart choice for HIV to set up shop. However, identifying HPCs as HIV hideouts shows researchers exactly what cell type to target. Collins’s team is doing just that - researching new treatment options that can target HPCs specifically, leaving other bone marrow cells unharmed to minimize collateral damage.

"Today's medications have side effects, as well as financial costs,” Collins pointed out. “To get to the next step, we need to target the types of cells that form a latent infection, including these progenitor cells."

According to the Centers for Disease Control and Prevention, over one million people in the United States are living with HIV, and 1 in 7 of them are completely unaware.

The present study was published in the journal PLOS Pathogens.

Source: Michigan Medicine/University of Michigan, CDC

 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 04, 2020
Coronavirus
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
NOV 04, 2020
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
COVID-19, the illness caused by the pandemic virus SARS-CoV-2, is known to cause blood clots all over the body in some p ...
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
DEC 01, 2020
Immunology
Scar-Free Healing Starts With Mobilizing the Immune System
DEC 01, 2020
Scar-Free Healing Starts With Mobilizing the Immune System
Thanks to a new hydrogel biomaterial developed by researchers at Duke University, we are one step closer to the holy gra ...
DEC 15, 2020
Immunology
Yes, You Should Get Your Flu Vaccine.
DEC 15, 2020
Yes, You Should Get Your Flu Vaccine.
A recent study published in Science Translational Medicine has provided fresh insights on how our immune systems protect ...
JAN 12, 2021
Immunology
Killer Control: Engineered Stem Cells Dodge Transplant Rejection
JAN 12, 2021
Killer Control: Engineered Stem Cells Dodge Transplant Rejection
The first organ transplant—performed over 60 years ago—was a success because the donor and recipient were id ...
JAN 26, 2021
Immunology
COVID Vaccine Reactions: You're As Likely to Be Struck by Lightning
JAN 26, 2021
COVID Vaccine Reactions: You're As Likely to Be Struck by Lightning
In a period of just over three weeks, over four million people received Moderna’s COVID-19 vaccine. Out of all the ...
Loading Comments...